22.05 23:15 | dpa-AFX: *ALIGN TECHNOLOGY APPOINTS EMORY WRIGHT, EVP DIRECT FABRICATION MANUFACTURING PLATFORM |
26.04 14:35 | dpa-AFX: *ALIGN TECHNOLOGY TO REPURCHASE $150 MLN OF COMMON STOCK |
24.04 22:07 | dpa-AFX: Align Technology Inc. Q1 Profit Increases, beats estimates |
24.04 22:06 | dpa-AFX: *ALIGN TECHNOLOGY Q1 EPS $1.39 VS. $1.14 YEAR AGO |
24.04 22:06 | dpa-AFX: *ALIGN TECHNOLOGY Q1 NET REVENUES $997.43 MLN VS. $943.15 MLN LAST YEAR |
24.04 22:06 | dpa-AFX: *ALIGN TECHNOLOGY Q1 NET INCOME $105.03 MLN VS. $87.80 MLN PRIOR YEAR |
24.04 12:01 | dpa-AFX: Align Technology Q1 24 Earnings Conference Call At 4:30 PM ET |
31.01 22:10 | dpa-AFX: *ALIGN TECHNOLOGY Q4 NET REVENUES $956.73 MLN VS. $901.52 MLN LAST YEAR |
31.01 22:10 | dpa-AFX: *ALIGN TECHNOLOGY Q4 NET INCOME $124.01 MLN VS. $41.78 MLN PRIOR YEAR |
31.01 22:10 | dpa-AFX: *ALIGN TECHNOLOGY Q4 EPS $1.64 VS. $0.54 YEAR AGO |
31.01 12:01 | dpa-AFX: Align Technology Q4 23 Earnings Conference Call At 4:30 PM ET |
03.01 22:05 | dpa-AFX: *ALIGN TECHNOLOGY COMPLETES ACQUISITION OF CUBICURE |
18.12 16:49 | dpa-AFX: Align Tech's Invisalign Palatal Expander System Receives FDA 510(k) Clearance |
18.12 15:37 | dpa-AFX: *FDA CLEARS ALIGN'S INVISALIGN PALATAL EXPANDER SYSTEM FOR COMMERCIAL AVAILABILITY IN THE U.S. |
11.12 12:38 | dpa-AFX: *GOLDMAN SENKT ALIGN TECHNOLOGY AUF 'SELL' (NEUTRAL) - ZIEL 197 (234) USD |
11.12 12:38 | dpa-AFX: *GOLDMAN CUTS ALIGN TECHNOLOGY TO 'SELL' (NEUTRAL) - PRICE TARGET 197 (234) USD |
05.12 22:19 | dpa-AFX: *MOJDEH POUL AND KEVIN CONROY JOIN ALIGN TECHNOLOGY BOARD OF DIRECTORS |
06.11 14:44 | dpa-AFX: Align Technology To Repurchase $100 Mln Of Common Stock |
06.11 14:33 | dpa-AFX: *ALIGN TECHNOLOGY PLANS TO REPURCHASE $100 MLN OF COMMON STOCK |
27.10 15:12 | dpa-AFX: Align Technology To Repurchase $250 Mln Shares |
|